1
TITLE: Results from the phase 2 trial of ridaforolimus, dalotuzumab, and exemestane compared to ridaforolimus and exemestane in advanced breast cancer
AUTHORS: Hope S Rugo; Olivier Tredan; Jungsil Ro; Serafin Morales; Antonino Musolino; Noemia Afonso; Marta Ferreira; Kyong Hwa Park; Javier Cortes; Antoinette R Tan; Joanne L Blum; Lamar Eaton; Christine K Gause; Adelle (Zhen) Wang; Ellie Im; David J Mauro; Jose Baselga;
PUBLISHED: 2015, SOURCE: 37th Annual CTRC-AACR San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 75, ISSUE: 9
INDEXED IN: WOS CrossRef